PHARMABCINE
PharmAbcine is a specialized biotech company that develops fully human therapeutic monoclonal antibody (mAb) using innovative discovery technology and excellent human resources for the treatment of human diseases, such as cancer and inflammatory diseases. Our mission is to develop a first-in-class and best-in-class mAb for those target diseases. PharmAbcine's business is mainly focused on out-licensing of candidate therapeutics and clinical application. For this purpose, we builds competiti... ve pipelines & drug discovery platform by in-house approach. When necessary, we consider extending strategic partnership for win-win business model. Our management team has expertise in all aspects of therapeutic antibody discovery and development, including marketing and we are also supported by world-class scientific advisors who are thought leaders in biology and medicine.
PHARMABCINE
Industry:
Biotechnology Health Care Therapeutics
Founded:
2008-01-01
Address:
Daejeon, Taejon-jikhalsi, South Korea
Country:
South Korea
Website Url:
http://www.pharmabcine.com
Total Employee:
11+
Status:
Active
Contact:
82 4 2863 2017
Total Funding:
6 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Apple Mobile Web Clips Icon Content Delivery Network Font Awesome Mobile Non Scaleable Content Nginx Euro Amazon
Similar Organizations
Apogenix
Apogenix is a biopharmaceutical company developing novel protein therapeutics for the treatment of cancer and inflammatory diseases.
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Dekkun
Dekkun develops a humanized monoclonal antibody, DKN-01, for the treatment of cancer and for strengthening cancer-associated bone lesions.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Mabpharm Private Ltd
Mabpharm is engaged in development of monoclonal antibodies for treatment of cancer and auto-immune diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
OrbiMed
OrbiMed investment in Series A - PharmAbcine
Green Cross
Green Cross investment in Series A - PharmAbcine
Novartis Venture Fund
Novartis Venture Fund investment in Series A - PharmAbcine
Tong Yang Venture Capital
Tong Yang Venture Capital investment in Series A - PharmAbcine
Official Site Inspections
http://www.pharmabcine.com Semrush global rank: 10.07 M Semrush visits lastest month: 54
- Host name: server-18-160-18-88.iad12.r.cloudfront.net
- IP address: 18.160.18.88
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
